AML specialist and researcher, Dr. Sangmin Lee, breaks down the recent advances in AML treatment and how targeted therapies are improving patient care.
Dr. Sangmin Lee is a hematologist-oncologist specializing in blood disorders and blood cancers at Weill Cornell Medicine and New York Presbyterian Hospital. More about Dr. Lee here: [ Ссылка ].
Related Programs:
AML Treatment Options: What’s Available? [ Ссылка ]
Can AML Be Cured? [ Ссылка ]
AML Genetic Testing Explained [ Ссылка ]
AML Treatment Advances: What’s New for YOU?
Теги
Acute Myeloid LeukemiaAMLAML SpecialistAML ExpertAcute Myelogenous LeukemiaDNAbone marrowoncogenesgenetic testinghematologygene mutationmyeloblastsacute myeloblastic leukemiaacute granulocytic leukemiaIDH1IDH2FLT3c-KITRASblood cancercomplete blood countCBChemoglobinFDAred blood cellscytogeneticsfluorescence in situ hybridizationFISH teststem cellsCAR T-Cell TherapyVenetoclaxDr. Sangmin LeeWeill Cornell Medicine
